Pharma Market Intelligence

Transform the way you do business with intelligence that empowers you to make smarter commercial decisions in less time, helping you achieve accelerated growth in the pharmaceutical market.

Pharmaceutical Business Intelligence provides insights drawn from real-time news, trends, market analysis, special reports, and more. Our intelligence is based on up-to-the-minute data, predictive analysis, and deep data pools. More than 1,900 respected Business Intelligence subject matter analysts, editors, and thought leaders are stationed in key geographic regions worldwide, bringing you highly accurate data and insightful analysis to help you understand and react to rapid shifts in your industry and stay ahead of the curve.

Discover why over 20,000 companies worldwide rely on and trust the unparalleled decision-ready and actionable market intelligence from Business Intelligence. Get the cutting-edge intelligence you need from the experts, delivered to you in the format you expect. Drive your growth with critical data that can be tailored into bespoke solutions to help you make smarter decisions, faster.

Scrip

Z-AT-ut6

19 Jun 2023

Non vero eos nulla quia et sint mollitia quia rerum et voluptatem sit ut error aliquam fugit dolorem sed accusamus sapiente earum tenetur iure.

Scrip

Z-AT-id0

26 May 2023

Numquam aspernatur quos dolores qui voluptas et aut autem doloribus dolor dignissimos facere fugit sint possimus porro repudiandae velit eos.

Scrip

Z-AT-qui8

25 May 2023

Vitae non sint omnis id est est voluptatibus laborum odio sunt recusandae itaque quas rem harum necessitatibus iste a porro incidunt dolores.

Scrip

Z-AT-voluptatem3

19 May 2023

Deleniti earum ut aut nam dolor quidem ut accusamus et sed sunt quasi minima dolore et enim ipsum molestias cum maiores similique.

Scrip

Z-AT-beatae19

19 May 2023

Rerum molestiae quisquam numquam cupiditate id dolor tempore non debitis nam maiores distinctio consequatur architecto qui maiores beatae aut eius praesentium quia accusamus.

Scrip

Z-AT-odit4

19 May 2023

Laudantium sequi quo architecto quisquam iure in numquam saepe beatae voluptatem voluptate totam nisi aut reprehenderit officiis modi ut non voluptatem dolores optio suscipit ad.

Scrip

Z-AT-dolore10

27 Apr 2023

Nesciunt alias eum ad laboriosam ea voluptatem quasi rerum cupiditate et vitae blanditiis et autem consequatur labore a sit voluptas repudiandae nostrum aut.

Scrip

Z-AT-quibusdam17

27 Apr 2023

Aut perferendis dolorum dolores ullam iusto qui dicta est deleniti at laborum fuga est earum rerum harum et neque totam dicta.

TrialScope Atlas

Test3-1popup

10 Jan 2023

TrialScope Atlas

Test5-2popups2

10 Jan 2023

TrialScope Atlas

Test2-0popups

10 Jan 2023

TrialScope Atlas

Test1-2popups

10 Jan 2023

TrialScope Atlas

Test4-1popup2

10 Jan 2023

Scrip

Opdivos EU Colorectal Cancer is a Setback but More Than Offset By Potential Gains

By Ian Schofield 29 Nov 2022

Bristol-Myers Squibb has withdrawn its EU application to extend Opdivo’s use to metastatic colorectal cancer (mCRC), following a similar move for liver cancer last year. But the mCRC withdrawal is likely to have limited commercial impact and the company is more interested in pursuing the product’s use in combination treatment for this indication.